Navigation Links
Novel mechanisms controlling insulin release and fat deposition discovered
Date:5/13/2008

[PRESS RELEASE, 13 May 200] Scientists at the Swedish medical university Karolinska Institutet have in two recent studies shown that a receptor called ALK7 plays important roles in the regulation of body fat deposition as well as the release of insulin from beta-cells in the pancreas. These findings have implications for the development of treatments against diabetes and obesity.

We have shown in animal studies that removing the ALK7 receptor improves insulin release by beta-cells in the pancreas, and at the same time decreases fat deposition in situations of high caloric intake, says Professor Carlos Ibez, who lead the two studies that are now published as back-to-back papers in the PNAS. The well-known connections between diabetes and obesity make our combined findings quite exciting.

Up to 6 per cent of the world population is estimated to suffer from some form of diabetes, either due to a reduced ability to produce insulin, or to insulin resistance. Insulin is a hormone required by cells in the body to absorb glucose from the blood, thereby providing them with energy. Obesity has been shown to increase the risk of developing diabetes, and as overweight becomes more prevalent in the human population, so do the cases of diabetes.

The research group led by Carlos Ibez studies how signaling by growth factors and their receptors regulate different physiological functions in the body. They have recently investigated the functions of one of these receptors, called ALK7, using mutant mice (knock-out mice) lacking this receptor. They found that in the absence of ALK7, mice developed abnormally high levels of insulin in the blood, which with age led to insulin resistance and liver steatosis, a pathological condition in which the liver enlarges and accumulates abnormally high levels of fat.

In collaboration with another research group at Karolinska Institutet, led by Professor Per-Olof Berggren, they also found that Calcium sig
'/>"/>

Contact: Katarina Sternudd
katarina.sternudd@ki.se
46-852-483-895
Karolinska Institutet
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease
2. Discovery of a novel mechanism for the development of colon cancer
3. TorreyPines Therapeutics Licenses Intellectual Property from Johns Hopkins Related to Novel Uses of Glutamate Receptor Antagonists for Prevention, Treatment of Stroke, Heart Attack
4. Latona Announces the Acquistion of Patent Rights and Orphan Drug Status to Novel Late Stage Drug Compound for Juvenile and Adult Rheumatoid Arthritis
5. Scientists identify novel way to prevent cardiac fibrosis
6. Registry unveils real-world data on novel excel stent
7. Researchers sharpen search for new marine medicines with novel techniques
8. Increased hepcidin expression: A novel oncogenic signalling mechanism
9. Novel discovery by Einstein scientists could lead to much-needed kidney failure treatment
10. Scripps Florida awarded $7.6 million grant to develop novel treatment for Parkinsons disease
11. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... 8 Allscripts-Misys Heal...hcare Solutions, Inc. (Allscripts or,the Company)...ree and six,months ended November 30, 2008. , ...061005/ALLSCRIPTSLOGO-b ) , The Company,s r... 30, 2008,include results from legacy Allscripts ...
(Date:1/8/2009)...an. 8 A new educational...uidance on drugs, biological products and medical ...d Quality,s Centers for Education and Research on ...k of more than a dozen leading research centers na...Information Network ( CHAIN ) http://www.chainonl...
(Date:1/8/2009)...Jan. 8 Heska Corporation...: , , , What: Heska Corporation Invite... Year-End 2008 Earnings Conference Call on the We....m. (MST], Where: www.heska.com (click on...Call link on the front page of this website)., ...
(Date:1/8/2009)...rist Missile Strikes , , NEW YORK, Jan. 8 /PRN...UJC) and the Jewish Federations of North America t...anitarian and social needs in southern Israel, par...lidarity with Israelis during the current conflict... of the Gaza Strip. , , The funds will enhance...
Breaking Medicine News(10 mins):Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics 2Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2
...just-published research study by Dr. R Preston Mas...ed that astaxanthin, a relatively //unknown carote... a viable scaffold for a new therapy to treat card...ional antioxidant properties in membrane models. C...
...ybe you ate a big, juicy steak for dinner last nig...known as triglycerides – to your system. For one i...ough we try to reduce fat in our diet, our bodies ...levated levels of fat in their bloodstream – nearl...
...e millions of Americans afflicted with Type 1 and ...uding: heart and kidney disease; //nerve damage an...inal disorders and hypoglycemia. Another major com...people per year, is permanent blindness due to dia...
...thers with more income and education may be less l...-date, a large new study finds. // Children in the...were more likely to have received the recommended ...ared to children of non-Hispanic white mothers. “T...
Other Medicine News:Health News:Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model 2Health News:Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model 3Health News:Sugars in Liver Found to Clear Fats from the Bloodstream 2Health News:Vision Loss Can Be Prevented in People With Diabetes 2Health News:Vision Loss Can Be Prevented in People With Diabetes 3Health News:Children’s Immunization Status Worsens as Mothers’ Income, Education Ri 2
(Date:1/6/2009)...Newswire/ -- Cequent Pharmaceuticals, a pioneer in...-based treatments to prevent and treat human disea...ted a successful toxicology study of its candidate...ic targeting the primary oncogene (beta-catenin, C...P is an inherited gastrointestinal disease that ca...
(Date:1/6/2009)... , - Early Renewa...il,December 2011 , - Expansion of the Scop...ery in Ophthalmology , - Revised Commercial...enses to a Third Party , ExonHit Therapeu...ement,of its existing drug discovery collaboratio...
(Date:1/5/2009)...RNewswire-FirstCall/ -- Micromet, Inc.,(Nasdaq: ...vel, proprietary,antibodies for the treatment of ...vides an outlook on key events anticipated for the... an update on its research and development,progra...o 16, 2009: Update on several preclinical BiTE ant...
(Date:1/3/2009)...ROSEMONT, Ill., Jan. 2 ...nology providing an increasing number of clinical ...according to an article in the January 2009 issue ...dic Surgeons ( http://www.jaaos.org/ ). It is pre...l technical developments will allow MRI to provide...
Breaking Medicine Technology:Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 3Medivir Reshapes Drug Discovery 5906 1Medivir Reshapes Drug Discovery 5906 2Medivir Reshapes Drug Discovery 5906 3Bug Zapper 3A A dose of radiation may help knock out malaria 1156 1Bug Zapper 3A A dose of radiation may help knock out malaria 1156 2Vioxx Ban Tied to Rise in Serious GI Trouble 5902 1Vioxx Ban Tied to Rise in Serious GI Trouble 5902 2Vioxx Ban Tied to Rise in Serious GI Trouble 5902 3Vioxx Ban Tied to Rise in Serious GI Trouble 5902 4HSPH Dean Barry R Bloom to receive honorary doctorate from Erasmus University Rotterdam 5899 1HSPH Dean Barry R Bloom to receive honorary doctorate from Erasmus University Rotterdam 5899 2
...ody Led to a Sustained Response and Remission in,F...Adequately,Tolerated in Patients with IV Steroid-R... 22, 2007 /PRNewswire-FirstCall/ -- Data,presented...week in,Washington D.C. by Dr. William Sandborn fr...b), an antibody in development as a,treatment for ...
...22, 2007 /PRNewswire-FirstCall/ -- Sosei Group,Cor...unces the,successful completion of a study of its ...gesic for the treatment of cancer,breakthrough pai...tre, open-label,single dose, cross-over, randomis...sal fentanyl citrate lozenge) and versus fentanyl,...
Other Medicine Technology:PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 2PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 3PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 4PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 5Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 2Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 3
...visitors is crucial for creating a secure and effi...with the Dynamic Hospital IdentifiOR, a highly-sca...it for hospitals of any size. IdentifiOR can be us...d component of existing enterprise systems. Identi...
...s a cost-effective and dependable performer to hel...metal construction, centralized printer/encoder ma...omplex multi-language font support, the R4Mplus is...ader/encoder supports a number of tag types, inclu...
...H 2824-Z direct thermal printer ensures reliable a...nd privacy. Generating clear bar codes, text, and ...24-Z direct thermal printeravailable only in the H... wristbands on demand. It can also print labels fo...
...us platform, the R170Xi for six-inch labels --off...lexibility in tag placement as well as unique feat...erprise systems, automatic calibration, flexible i...s tracking, easier RFID programming and more detai...
Medicine Products: